N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Trea...
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
About this item
Full title
Author / Creator
Conus, Philippe , Seidman, Larry J , Fournier, Margot , Xin, Lijing , Cleusix, Martine , Baumann, Philipp S , Ferrari, Carina , Cousins, Ann , Alameda, Luis , Gholam-Rezaee, Mehdi , Golay, Philippe , Jenni, Raoul , Woo, T -U Wilson , Keshavan, Matcheri S , Eap, Chin B , Wojcik, Joanne , Cuenod, Michel , Buclin, Thierry , Gruetter, Rolf and Do, Kim Q
Publisher
United States: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
United States: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Biomarker-guided treatments are needed in psychiatry, and previous data suggest oxidative stress may be a target in schizophrenia. A previous add-on trial with the antioxidant N-acetylcysteine (NAC) led to negative symptom reductions in chronic patients. We aim to study NAC's impact on symptoms and neurocognition in early psychosis (EP) and to expl...
Alternative Titles
Full title
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
Authors, Artists and Contributors
Author / Creator
Seidman, Larry J
Fournier, Margot
Xin, Lijing
Cleusix, Martine
Baumann, Philipp S
Ferrari, Carina
Cousins, Ann
Alameda, Luis
Gholam-Rezaee, Mehdi
Golay, Philippe
Jenni, Raoul
Woo, T -U Wilson
Keshavan, Matcheri S
Eap, Chin B
Wojcik, Joanne
Cuenod, Michel
Buclin, Thierry
Gruetter, Rolf
Do, Kim Q
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5815074
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5815074
Other Identifiers
ISSN
0586-7614
E-ISSN
1745-1701
DOI
10.1093/schbul/sbx093
